CATX
Perspective Therapeutics, Inc.
+0.18 (+6.85%)2.89USD501K成交股數329M市值–本益比(近四季)229.7股價營收比–營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | −4.9M | 2.2M | 2.1M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | 1.4M | 1.8M |
| 毛利 | – | – | – | – | – | – | – | – | – | −39K | 738K | 248K |
| 毛利率 | – | – | – | – | – | – | – | – | – | 0.8% | 33.8% | 11.9% |
| 研發費用 | 21.5M | 21.4M | 32.9M | 20.3M | 16.6M | 14.3M | 12.0M | 9.3M | 7.5M | 7.1M | 5.6M | 5.4M |
| 銷售管理費用 | 7.8M | 7.0M | 7.0M | 7.7M | 7.7M | 7.8M | 7.0M | 5.5M | 5.9M | 4.9M | 4.5M | 5.0M |
| 營業利益 | −29.3M+22% | −28.3M+30% | −39.8M+114% | −27.9M+95% | −24.0M+85% | −21.8M+87% | −18.6M+91% | −14.3M+46% | −13.0M | −11.7M | −9.8M | −9.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | 238.2% | -446.2% | -467.1% |
| 稅後淨利 | −26.8M+25% | −26.2M+44% | −37.5M+148% | −26.0M+122% | −21.5M+75% | −18.2M-26% | −15.1M+46% | −11.7M+5% | −12.3M | −24.7M | −10.4M | −11.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | 503.4% | -474.0% | -531.9% |
| 稀釋 EPS | -0.22-24% | -0.250% | -0.51+143% | -0.35+94% | -0.29+16% | -0.25-74% | -0.21-43% | -0.18-55% | -0.25 | -0.97 | -0.37 | -0.40 |
| 稀釋股數 | 121M | 104M | 73.8M | 74.3M | 74.2M | 72.4M | 70.6M | 66.6M | 49.5M | 26.8M | 28.1M | 28.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 48.5M | 54.0M | 30.6M | 26.8M | 28.8M | 44.4M | 226M | 252M | 142M | 9.2M | 18.0M | 28.3M |
| 應收帳款 | 269K | 58K | 6K | 179K | 225K | 78K | 217K | 142K | 999K | 1.2M | 1.7M | 1.1M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | 1.0M | 1.1M |
| 總資產 | 392M | 411M | 267M | 295M | 311M | 329M | 391M | 386M | 278M | 97.9M | 111M | 120M |
| 有息負債 | 1.6M | 1.6M | 1.6M | 1.6M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 1.8M |
| 總負債 | 68.2M | 63.3M | 59.9M | 52.6M | 45.0M | 44.7M | 62.7M | 44.9M | 48.4M | 22.7M | 11.7M | 11.5M |
| 股東權益 | 324M | 347M | 207M | 242M | 266M | 285M | 328M | 341M | 230M | 75.2M | 98.8M | 109M |
| 負債比 | 17.4% | 15.4% | 22.5% | 17.8% | 14.5% | 13.6% | 16.0% | 11.6% | 17.4% | 23.2% | 10.6% | 9.6% |
| 淨現金(現金 − 有息負債) | 46.9M | 52.4M | 29.0M | 25.1M | 27.2M | 42.7M | 225M | 250M | 140M | 7.5M | 16.2M | 26.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −31.5M+46% | – | – | – | −21.6M | – | – | 13.8M | – | – | – |
| 資本支出 | – | 6.9M | – | – | – | 4.7M | – | – | 9.1M | – | – | – |
| 自由現金流 | – | −38.3M+46% | – | – | – | −26.2M | – | – | 4.8M | – | – | – |
| 折舊攤銷 | – | 1.1M | – | – | – | 732K | – | – | 356K | 282K | 259K | 255K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −103M | –% | -1.40 | −95.2M |
| FY2024 | – | – | −79.3M | –% | -1.23 | −72.7M |
| FY2023 | 1.4M | – | −46.5M | -3,243.2% | -1.74 | −38.0M |
| FY2022 | 0.00 | -100.0% | −10.8M | –% | – | −10.7M |
| FY2022 | 10.8M | +7.4% | −7.3M | -67.4% | – | −8.0M |
| FY2021 | 10.1M | +3.9% | −3.4M | -33.7% | -0.03 | −3.2M |
| FY2020 | 9.7M | +32.3% | −3.4M | -35.6% | -0.05 | −3.9M |
| FY2019 | 7.3M | – | −5.1M | -70.3% | -0.08 | −5.5M |